Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

517
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
517
Cancer Vaccines01:30

Cancer Vaccines

569
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
569
Vaccinations01:51

Vaccinations

46.6K
Overview
46.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogen-induced modulation of the volatile metabolome of Hanseniaspora uvarum LE-1 and its role in post-harvest disease suppression.

World journal of microbiology & biotechnology·2026
Same author

α-C-H Functionalization of Benzylamines: A Crucial Yet Challenging Transformation.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Medical student's attitude towards learning medical ethics in India.

Bioinformation·2026
Same author

Enhanced diagnostic tools for visceral leishmaniasis using kinase based antigens in Brazilian human and canine samples.

Scientific reports·2026
Same author

Unveiling bioactive components of <i>Gymnema sylvestre</i> for antimycotic potential and process optimization.

Food science and biotechnology·2026
Same author

Amplitude and phase modulation of SH waves by resonant scattering at PZT-5A/BaTiO<sub>3</sub> imperfect boundary.

Ultrasonics·2025

Related Experiment Video

Updated: Oct 19, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

1.9K

Nanovaccine: an emerging strategy.

Amrita Das1, Nahid Ali1

  • 1Infectious Diseases and Immunology Division, CSIR-Indian Institute of Chemical Biology, Kolkata, India.

Expert Review of Vaccines
|September 22, 2021
PubMed
Summary
This summary is machine-generated.

Nanoparticle vaccines offer a promising strategy to overcome the limitations of traditional vaccines. These nanovaccines enhance targeted delivery and immune response for infectious diseases and cancer therapy.

Keywords:
COVID-19Nanoparticleadjuvantcancerinfectionnanovaccine

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.8K

Related Experiment Videos

Last Updated: Oct 19, 2025

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo

Published on: September 28, 2022

1.9K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.7K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.8K

Area of Science:

  • Immunology
  • Nanotechnology
  • Vaccine Development

Background:

  • Traditional vaccines face challenges with eliciting strong, long-lasting immunity.
  • Emerging drug resistance and cancer treatment toxicities necessitate advanced vaccine solutions.
  • Subunit vaccines alone often fail to provide adequate protection.

Purpose of the Study:

  • To review emerging nanoparticle (NP)-based vaccine strategies for infectious diseases and cancer.
  • To highlight the successes and challenges of nanovaccines in preclinical and clinical trials.
  • To provide an overview of current nanovaccine technologies, adjuvant potential, and cellular delivery.

Main Methods:

  • Literature review of nanoparticle-based vaccine strategies.
  • Analysis of preclinical and clinical trial data for nanovaccines.
  • Summary of nanovaccine design, adjuvant properties, and immune mechanisms.

Main Results:

  • Nanoparticle delivery vehicles (e.g., microemulsions, liposomes, nanogels) show promise in overcoming traditional vaccine adjuvant limitations.
  • Nanovaccines improve targeted delivery, antigen presentation, and innate immune stimulation.
  • Nanovaccines can induce strong T cell responses and are beneficial for cancer immunotherapy.

Conclusions:

  • Nanovaccines (50-250 nm) are efficient due to optimal size for tissue targeting and immune cell uptake.
  • Future nanovaccine development goals include rational design, improved antigen loading, functionalization, and targeted delivery.
  • Nanovaccines represent a significant advancement in combating infectious diseases and developing cancer therapeutics.